Japan’s healthcare providers, medical device companies, payers and policymakers face a fast-moving care-delivery challenge: more patients need continuous support, while the traditional hospital-centered model faces mounting pressure. The Japan Home Healthcare Market is becoming a major response mechanism, with demand moving toward connected devices, remote monitoring and home-based clinical services.
The Japan Home Healthcare Market Size was valued at USD 24.29 billion in 2023 and is projected to reach nearly USD 44.23 billion by 2030, expanding at a CAGR of 8.94% from 2023 to 2030. That growth signals a substantial commercial opportunity for providers that can deliver reliable, technology-enabled care outside acute-care settings.
Key Highlights
- Japan Home Healthcare Market size reached USD 24.29 billion in 2023.
- Market revenue is forecast to reach nearly USD 44.23 billion by 2030.
- The market is expected to grow at a CAGR of 8.94% during 2023–2030.
- Cardiovascular Diseases and Hypertension held more than 25% market share in 2023.
- The cardiovascular segment is projected to grow at a CAGR of 9.2%.
- Diabetes is expected to be the fastest-growing indication segment.
- Telemedicine, remote monitoring devices and artificial intelligence are expanding the home-care delivery model.
- Major participants include Medtronic Japan, A&D Company, Panasonic Healthcare, Omron Healthcare, Philips Healthcare, Nihon Kohden and Terumo Corporation.
Why This Matters Now
Japan’s home healthcare market is moving from a support category to a strategic part of healthcare delivery. A rapidly aging population, rising chronic disease prevalence and patient preference for treatment at home are increasing demand for services that reduce the need for repeated hospital visits.
The market’s projected rise from USD 24.29 billion in 2023 to USD 44.23 billion in 2030 creates pressure on healthcare providers to redesign care pathways. Providers that can integrate skilled nursing, rehabilitation, respiratory care, remote monitoring and chronic disease management into a coordinated home-care model stand to capture a larger share of future patient demand.
For investors, the opportunity extends beyond home visits. The market includes testing, screening and monitoring devices, therapeutic devices, mobility assistance products and care services. This broad structure opens opportunities for device makers, digital health companies, telecom operators, care providers, insurers and service platforms.
Market Overview
Japan home healthcare includes devices and services used to support patient treatment, monitoring, rehabilitation and daily care outside hospitals and clinics. The sector covers blood glucose monitors, blood pressure monitors, pulse oximeters, sleep apnea monitors, oxygen delivery systems, ventilators, dialysis equipment, insulin delivery devices, mobility aids and professional care services.
The market is expanding as patients seek treatment options that are more convenient, personalized and compatible with long-term disease management. Home healthcare can support patients who require regular monitoring but do not always need inpatient care. That changes the economics of treatment delivery by shifting a greater share of routine care into the home.
Japan’s demographic profile is central to the market’s growth. The report states that nearly 30% of the country’s population is expected to be aged 65 and above by 2030. This creates a larger pool of patients requiring ongoing management for cardiovascular conditions, hypertension, diabetes, respiratory diseases, mobility disorders and other chronic health needs.
Key Trends Driving Growth
The most important trend is the expansion of technology-enabled home care. Telemedicine platforms, remote monitoring devices and artificial intelligence are changing how healthcare professionals track patients outside clinical facilities. These tools can support faster intervention, more frequent monitoring and better coordination between patients, caregivers and providers.
For medical device companies, the shift raises demand for connected monitoring products that can provide usable patient data. Blood pressure monitors, glucose monitoring systems, pulse oximeters and heart-rate monitoring devices are becoming more relevant as providers seek to manage chronic conditions before they lead to emergency treatment.
Patient preferences are also reshaping the market. Many older patients prefer receiving care in familiar home environments rather than traveling frequently to hospitals or clinics. This preference supports demand for home nursing, rehabilitation therapy, respiratory therapy, infusion therapy and palliative care services.
Government policies and healthcare infrastructure development are further supporting the market. The report identifies policy support, healthcare infrastructure, demographic shifts and technological advancement as major growth factors. For healthcare systems, home-based care offers a route to expand access while managing the operational burden created by long-term chronic care.
Request a Free Sample Report for Comprehensive Market Insights
Segment Insights
- Dominant Segment: Cardiovascular Diseases and Hypertension — This segment held more than 25% of the Japan Home Healthcare Market in 2023. It is expected to grow at a CAGR of 9.2% through the forecast period. Heart disease is identified as the leading cause of death in Japan, affecting one in three men and one in four women. Hypertension affects more than 40% of the adult population, making home blood-pressure monitoring and ongoing cardiovascular management a major commercial and clinical priority.
- Fastest-Growing Segment: Diabetes — The diabetes segment is expected to grow rapidly during the forecast period. Japan has an estimated 10.5 million people with diabetes, equal to one in 12 adults. Rising use of telehealth, wearable devices and remote monitoring systems is expected to support more personalized diabetes care at home.
- Device Opportunity: Testing, Screening and Monitoring Devices — Blood glucose monitors, blood pressure monitors, heart-rate monitors, sleep apnea monitors, pulse oximeters and home hemoglobin A1C test kits are positioned to benefit from chronic disease management needs. Their value lies in enabling earlier intervention and reducing the need for frequent facility-based testing.
- Therapeutic Device Opportunity: Respiratory and Chronic Care Products — Oxygen delivery systems, nebulizers, ventilators, sleep apnea therapeutic devices, dialysis equipment, wound care products and insulin delivery devices support the shift toward home-based treatment for complex conditions.
- Service Opportunity: Skilled and Specialized Care — Skilled nursing, rehabilitation therapy, hospice and palliative care, respiratory therapy, infusion therapy and pregnancy care services create recurring demand for providers with workforce capacity and integrated care capabilities.
Regional Growth Story
Japan is the central growth market in this analysis, driven by a combination of aging demographics, chronic disease prevalence, technology adoption and policy support for home-based care. The country’s healthcare infrastructure is increasingly being tested by patients who need long-duration support rather than short episodes of acute treatment.
The growth story is not simply about adding more home-care visits. It is about connecting devices, clinicians, caregivers and patients through digital systems. Telehealth and remote monitoring can help providers maintain contact with patients between appointments, while artificial intelligence can support more efficient use of patient data.
Japan’s experience also carries broader relevance for healthcare markets in the United States, Germany, the United Kingdom, China, India and South Korea. These markets are also managing higher chronic disease burdens, demand for accessible care and pressure to improve care efficiency. Japan’s home healthcare expansion shows how aging populations can accelerate investment in connected care models.
Competitive Landscape
Competition in Japan’s home healthcare market spans medical device manufacturers, digital health providers, healthcare service companies, telecom-linked healthcare platforms and home-support businesses. Major companies include Medtronic Japan, Doctor mate, A&D Company, Toto, Panasonic Healthcare, Omron Healthcare, Philips Healthcare, Nihon Kohden, Terumo Corporation, LITALICO, Nichii Gakkan Group, Recruit Holdings, NTT Docomo Healthcare and ALSOK.
The competitive advantage is shifting toward companies that can combine devices, data and services. A device maker that sells a blood pressure monitor without connectivity faces a different market position than one that can integrate monitoring data into telehealth workflows. Similarly, service providers that can coordinate skilled nursing, rehabilitation and remote clinical oversight may gain stronger patient retention.
The presence of telecom and technology-linked players points to a broader market direction. Home healthcare is becoming a connected service ecosystem, not only a product market. Companies that can support secure data exchange, patient engagement and provider coordination are likely to gain importance as care delivery becomes more digital.
Recent Developments
- Telemedicine platforms are expanding the ability of providers to deliver consultations and follow-up care without requiring patients to travel.
- Remote monitoring devices are increasing the use of home-based data collection for cardiovascular disease, hypertension and diabetes management.
- Artificial intelligence is being integrated into healthcare infrastructure to support more connected and patient-focused care delivery.
- Wearable devices and digital monitoring systems are creating new opportunities for personalized diabetes management at home.
- Healthcare companies are increasing investment in connectivity and data exchange capabilities to improve coordination between providers and patients.
Strategic Implications
Healthcare providers need to treat home healthcare as a core operating model rather than a peripheral service. The strongest providers will build integrated pathways that connect hospital discharge planning, remote monitoring, home nursing, rehabilitation and chronic disease follow-up.
Medical device manufacturers need to focus on clinical usability and digital integration. Demand is rising for products that can provide reliable monitoring data and fit into wider telehealth systems. This is especially important in cardiovascular care, hypertension management and diabetes treatment.
Payers and policymakers face a parallel challenge. Reimbursement systems, regulatory standards and care-quality frameworks will influence how quickly home healthcare scales. The report identifies reimbursement issues and regulatory challenges as market restraints, making policy clarity important for long-term investment.
Future Outlook
Japan’s home healthcare market will be led by organizations that turn chronic disease monitoring, connected devices and home-based services into one coordinated patient-care system.
Analyst Perspective
“Japan’s home healthcare market is moving toward a more connected and patient-centered model as aging demographics and chronic disease prevalence increase demand for care outside traditional facilities,” said Komal Patil, Analyst at Maximize Market Research. “The companies that combine remote monitoring, telehealth capabilities and specialized home-care services will be better positioned to serve the country’s expanding long-term care needs.”
About Maximize Market Research
Maximize Market Research Pvt. Ltd. (MMR) is a global market research and consulting company that provides reliable, data-focused, and practical business insights. The firm serves a wide range of industries, including healthcare, pharmaceuticals, technology, automotive, electronics, chemicals, personal care, and consumer goods. Through market forecasts, competitive analysis, strategic consulting, and industry impact assessments, MMR helps organizations understand changing market conditions, identify growth opportunities, and make informed business decisions for long-term success.
Contact Us
2nd Floor, Navale IT Park Phase 3
Pune Banglore Highway, Narhe
Pune, Maharashtra 411041, India
+91 9607365656
[email protected]